Curcumin and chronic kidney disease (CKD): Major mode of action through stimulating endogenous intestinal alkaline phosphatase

Molecules

Volumn 19, Issue 12, 2014, Pages 20139-20156

  Ghosh, Siddhartha S ^a   Gehr, Todd W B ^a   Ghosh, Shobha ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Cytokines; Diabetes; Inflammation; Intestinal alkaline phosphatase; Intestinal permeability

Indexed keywords

ALKALINE PHOSPHATASE; AUTACOID; CURCUMIN;

BIOAVAILABILITY; DRUG EFFECTS; ENZYMOLOGY; GASTROINTESTINAL TRACT; HUMAN; METABOLISM; PATHOLOGY; RENAL INSUFFICIENCY, CHRONIC;

ALKALINE PHOSPHATASE; BIOLOGICAL AVAILABILITY; CURCUMIN; GASTROINTESTINAL TRACT; HUMANS; INFLAMMATION MEDIATORS; RENAL INSUFFICIENCY, CHRONIC;

EID: 84919741025     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules191220139     Document Type: Review

References (90)

1. Himmelfarb, J.; Stenvinkel, P.; Ikizler, T.A.; Hakim, R.M. The Elephant in Uremia: Oxidant Stress as a Unifying Concept of Cardiovascular Disease in Uremia. Kidney Int. 2002, 62, 1524-1538.
2. Moradi, H.; Sica, D.A.; Kalantar-Zadeh, K. Cardiovascular Burden Associated with Uremic Toxins in Patients with Chronic Kidney Disease. Am. J. Nephrol. 2013, 38, 136-148.
3. Lozano, R.; Naghavi, M.; Foreman, K.; Lim, S.; Shibuya, K.; Aboyans, V.; Abraham, J.; Adair, T.; Aggarwal, R.; Ahn, S.Y.; et al. Global and Regional Mortality from 235 Causes of Death for 20 Age Groups in 1990 and 2010: A Systematic Analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380, 2095-2128.
4. Jha, V.; Garcia-Garcia, G.; Iseki, K.; Li, Z.; Naicker, S.; Plattner, B.; Saran, R.; Wang, A.Y.; Yang, C.W. Chronic Kidney Disease: Global Dimension and Perspectives. Lancet 2013, 382, 260-272.
5. Singh, A.K.; Kari, J.A. Metabolic Syndrome and Chronic Kidney Disease. Curr. Opin. Nephrol. Hypertens. 2013, 22, 198-203.
6. Gupta, S.C.; Patchva, S.; Aggarwal, B.B. Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials. AAPS J. 2013, 15, 195-218.
7. Hatcher, H.; Planalp, R.; Cho, J.; Torti, F.M.; Torti, S.V. Curcumin: From Ancient Medicine to Current Clinical Trials. Cell. Mol. Life Sci. 2008, 65, 1631-1652.
8. Aggarwal, B.B. Targeting Inflammation-Induced Obesity and Metabolic Diseases by Curcumin and Other Nutraceuticals. Annu. Rev. Nutr. 2010, 30, 173-199.
9. Aggarwal, B.B.; Sung, B. Pharmacological Basis for the Role of Curcumin in Chronic Diseases: An Age-Old Spice with Modern Targets. Trends Pharmacol. Sci. 2009, 30, 85-94.
10. Prasad, S.; Gupta, S.C.; Tyagi, A.K.; Aggarwal, B.B. Curcumin, a Component of Golden Spice: From Bedside to Bench and Back. Biotechnol. Adv. 2014, 32, 1053-1064.
11. Shishodia, S. Molecular Mechanisms of Curcumin Action: Gene Expression. Biofactors 2013, 39, 37-55.
12. Rios, A.; Vargas-Robles, H.; Gamez-Mendez, A.M.; Escalante, B. Cyclooxygenase-2 and Kidney Failure. Prostaglandins Other Lipid Mediat. 2012, 98, 86-90.
13. Horiba, N.; Kumano, E.; Watanabe, T.; Shinkura, H.; Sugimoto, T.; Inoue, M. Subtotal Nephrectomy Stimulates Cyclooxygenase 2 Expression and Prostacyclin Synthesis in the Rat Remnant Kidney. Nephron 2002, 91, 134-141.
14. Ghosh, S.S.; Krieg, R.; Massey, H.D.; Sica, D.A.; Fakhry, I.; Ghosh, S.; Gehr, T.W. Curcumin and Enalapril Ameliorate Renal Failure by Antagonizing Inflammation in 5/6 Nephrectomized Rats: Role of Phospholipase and Cyclooxygenase. Am. J. Physiol. Ren. Physiol. 2012, 302, F439-F454.
15. Maccarrone, M.; Taccone-Gallucci, M.; Finazzi-Agro, A. 5-Lipoxygenase-Mediated Mitochondrial Damage and Apoptosis of Mononuclear Cells in ESRD Patients. Kidney Int. 2003, 63, S33-S36.
16. Radmark, O.; Samuelsson, B. 5-Lipoxygenase: Regulation and Possible Involvement in Atherosclerosis. Prostaglandins Other Lipid Mediat. 2007, 83, 162-174.
17. Stenvinkel, P. Inflammatory and Atherosclerotic Interactions in the Depleted Uremic Patient. Blood Purif. 2001, 19, 53-61.
18. Stenvinkel, P.; Ketteler, M.; Johnson, R.J.; Lindholm, B.; Pecoits-Filho, R.; Riella, M.; Heimburger, O.; Cederholm, T.; Girndt, M. IL-10, IL-6, and TNF-Alpha: Central Factors in the Altered Cytokine Network of Uremia-The Good, the Bad, and the Ugly. Kidney Int. 2005, 67, 1216-1233.
19. Fink, H.A.; Ishani, A.; Taylor, B.C.; Greer, N.L.; MacDonald, R.; Rossini, D.; Sadiq, S.; Lankireddy, S.; Kane, R.L.; Wilt, T.J. Screening for, Monitoring, and Treatment of Chronic Kidney Disease Stages 1 to 3: A Systematic Review for the U.S. Preventive Services Task Force and for an American College of Physicians Clinical Practice Guideline. Ann. Intern. Med. 2012, 156, 570-581.
20. Shing, C.M.; Adams, M.J.; Fassett, R.G.; Coombes, J.S. Nutritional Compounds Influence Tissue Factor Expression and Inflammation of Chronic Kidney Disease Patients in Vitro. Nutrition 2011, 27, 967-972.
21. Moreillon, J.J.; Bowden, R.G.; Deike, E.; Griggs, J.; Wilson, R.; Shelmadine, B.; Cooke, M.; Beaujean, A. The use of an Anti-Inflammatory Supplement in Patients with Chronic Kidney Disease. J. Complement. Integr. Med. 2013, 10, 1-10.
22. Choi, B.H.; Kang, K.S.; Kwak, M.K. Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease. Molecules 2014, 19, 12727-12759.
23. Soetikno, V.; Watanabe, K.; Sari, F.R.; Harima, M.; Thandavarayan, R.A.; Veeraveedu, P.T.; Arozal, W.; Sukumaran, V.; Lakshmanan, A.P.; Arumugam, S.; et al. Curcumin Attenuates Diabetic Nephropathy by Inhibiting PKC-Alpha and PKC-beta1 Activity in Streptozotocin-Induced Type I Diabetic Rats. Mol. Nutr. Food Res. 2011, 55, 1655-1665.
24. Sanchez-Lozada, L.G.; Tapia, E.; Soto, V.; Avila-Casado, C.; Franco, M.; Wessale, J.L.; Zhao, L.; Johnson, R.J. Effect of Febuxostat on the Progression of Renal Disease in 5/6 Nephrectomy Rats with and without Hyperuricemia. Nephron Physiol. 2008, 108, p69-p78.
25. Ghosh, S.S.; Krieg, R.; Sica, D.A.; Fakhry, I.; Mirshahi, S.; Gehr, T.W.B. Role of Pla2 and Arachidonic Acid Metabolism in Inflammation during Renal Failure. J. Am. Soc. Nephrol. 2008, 19, 852.
26. Small, D.M.; Coombes, J.S.; Bennett, N.; Johnson, D.W.; Gobe, G.C. Oxidative Stress, Anti-Oxidant Therapies and Chronic Kidney Disease. Nephrology 2012, 17, 311-321.
27. Cybulsky, A.V. Growth Factor Pathways in Proliferative Glomerulonephritis. Curr. Opin. Nephrol. Hypertens. 2000, 9, 217-223.
28. Lopez-Hernandez, F.J.; Lopez-Novoa, J.M. Role of TGF-Beta in Chronic Kidney Disease: An Integration of Tubular, Glomerular and Vascular Effects. Cell Tissue Res. 2012, 347, 141-154.
29. Khajehdehi, P.; Pakfetrat, M.; Javidnia, K.; Azad, F.; Malekmakan, L.; Nasab, M.H.; Dehghanzadeh, G. Oral Supplementation of Turmeric Attenuates Proteinuria, Transforming Growth Factor-Beta and Interleukin-8 Levels in Patients with Overt Type 2 Diabetic Nephropathy: A Randomized, Double-Blind and Placebo-Controlled Study. Scand. J. Urol. Nephrol. 2011, 45, 365-370.
30. Ghosh, S.S.; Gehr, T.W.; Ghosh, S.; Fakhry, I.; Sica, D.A.; Lyall, V.; Schoolwerth, A.C. PPARgamma Ligand Attenuates PDGF-Induced Mesangial Cell Proliferation: Role of MAP Kinase. Kidney Int. 2003, 64, 52-62.
31. Nakagawa, T.; Sato, W.; Kosugi, T.; Johnson, R.J. Uncoupling of VEGF with Endothelial NO as a Potential Mechanism for Abnormal Angiogenesis in the Diabetic Nephropathy. J. Diabetes Res. 2013, 2013, 184539.
32. Zhang, F.; Zhang, Z.; Chen, L.; Kong, D.; Zhang, X.; Lu, C.; Lu, Y.; Zheng, S. Curcumin Attenuates Angiogenesis in Liver Fibrosis and Inhibits Angiogenic Properties of Hepatic Stellate Cells. J. Cell. Mol. Med. 2014, 18, 1392-1406.
33. Ghosh, S.S.; Salloum, F.N.; Abbate, A.; Krieg, R.; Sica, D.A.; Gehr, T.W.; Kukreja, R.C. Curcumin Prevents Cardiac Remodeling Secondary to Chronic Renal Failure through Deactivation of Hypertrophic Signaling in Rats. Am. J. Physiol. Heart Circ. Physiol. 2010, 299, H975-H984.
34. Ye, J. Regulation of PPARgamma Function by TNF-Alpha. Biochem. Biophys. Res. Commun. 2008, 374, 405-408.
35. Ghosh, S.S.; Massey, H.D.; Krieg, R.; Fazelbhoy, Z.A.; Ghosh, S.; Sica, D.A.; Fakhry, I.; Gehr, T.W. Curcumin Ameliorates Renal Failure in 5/6 Nephrectomized Rats: The Role of Inflammation. Am. J. Physiol. Ren. Physiol. 2009, 296, 1146-1157.
36. Uwe, S. Anti-Inflammatory Interventions of NF-kappaB Signaling: Potential Applications and Risks. Biochem. Pharmacol. 2008, 75, 1567-1579.
37. Oeckinghaus, A.; Hayden, M.S.; Ghosh, S. Crosstalk in NF-kappaB Signaling Pathways. Nat. Immunol. 2011, 12, 695-708.
38. Guijarro, C.; Egido, J. Transcription Factor-Kappa B (NF-Kappa B) and Renal Disease. Kidney Int. 2001, 59, 415-424.
39. Pedruzzi, L.M.; Stockler-Pinto, M.B.; Leite, M., Jr.; Mafra, D. Nrf2-keap1 System Versus NF-kappaB: The Good and the Evil in Chronic Kidney Disease? Biochimie 2012, 94, 2461-2466.
40. Fujihara, C.K.; Antunes, G.R.; Mattar, A.L.; Malheiros, D.M.; Vieira, J.M., Jr.; Zatz, R. Chronic Inhibition of Nuclear Factor-kappaB Attenuates Renal Injury in the 5/6 Renal Ablation Model. Am. J. Physiol. Ren. Physiol. 2007, 292, F92-F99.
41. Zoja, C.; Benigni, A.; Remuzzi, G. The Nrf2 Pathway in the Progression of Renal Disease. Nephrol. Dial. Transplant. 2014, doi:10.1093/ndt/gft224.
42. Kim, H.J.; Vaziri, N.D. Contribution of Impaired Nrf2-Keap1 Pathway to Oxidative Stress and Inflammation in Chronic Renal Failure. Am. J. Physiol. Renal Physiol. 2010, 298, F662-F671.
43. Zoja, C.; Abbate, M.; Remuzzi, G. Progression of Renal Injury toward Interstitial Inflammation and Glomerular Sclerosis is Dependent on Abnormal Protein Filtration. Nephrol. Dial. Transplant. 2014, doi:10.1093/ndt/gfu261.
44. Dinkova-Kostova, A.T.; Massiah, M.A.; Bozak, R.E.; Hicks, R.J.; Talalay, P. Potency of Michael Reaction Acceptors as Inducers of Enzymes that Protect Against Carcinogenesis Depends on their Reactivity with Sulfhydryl Groups. Proc. Natl. Acad. Sci. USA 2001, 98, 3404-3409.
45. Dinkova-Kostova, A.T.; Talalay, P. Relation of Structure of Curcumin Analogs to their Potencies as Inducers of Phase 2 Detoxification Enzymes. Carcinogenesis 1999, 20, 911-914.
46. Soetikno, V.; Sari, F.R.; Lakshmanan, A.P.; Arumugam, S.; Harima, M.; Suzuki, K.; Kawachi, H.; Watanabe, K. Curcumin Alleviates Oxidative Stress, Inflammation, and Renal Fibrosis in Remnant Kidney through the Nrf2-keap1 Pathway. Mol. Nutr. Food Res. 2013, 57, 1649-1659.
47. Kon, V.; Linton, M.F.; Fazio, S. Atherosclerosis in Chronic Kidney Disease: The Role of Macrophages. Nat. Rev. Nephrol. 2011, 7, 45-54.
48. Jacob, A.; Chaves, L.; Eadon, M.T.; Chang, A.; Quigg, R.J.; Alexander, J.J. Curcumin Alleviates Immune-Complex-Mediated Glomerulonephritis in Factor-H-Deficient Mice. Immunology 2013, 139, 328-337.
49. Cohen, D.L.; Townsend, R.R. Hypertension and Kidney Disease: What do the Data really show? Curr. Hypertens. Rep. 2012, 14, 462-467.
50. Garimella, P.S.; Uhlig, K. Current Issues in the Management and Monitoring of Hypertension in Chronic Kidney Disease. Curr. Opin. Nephrol. Hypertens. 2013, 22, 599-606.
51. Tapia, E.; Soto, V.; Ortiz-Vega, K.M.; Zarco-Marquez, G.; Molina-Jijon, E.; Cristobal-Garcia, M.; Santamaria, J.; Garcia-Nino, W.R.; Correa, F.; Zazueta, C.; et al. Curcumin Induces Nrf2 Nuclear Translocation and Prevents Glomerular Hypertension, Hyperfiltration, Oxidant Stress, and the Decrease in Antioxidant Enzymes in 5/6 Nephrectomized Rats. Oxidative Med. Cell. Longev. 2012, 2012, doi:10.1155/2012/269039.
52. Tapia, E.; Zatarain-Barron, Z.L.; Hernandez-Pando, R.; Zarco-Marquez, G.; Molina-Jijon, E.; Cristobal-Garcia, M.; Santamaria, J.; Pedraza-Chaverri, J. Curcumin Reverses Glomerular Hemodynamic Alterations and Oxidant Stress in 5/6 Nephrectomized Rats. Phytomedicine 2013, 20, 359-366.
53. Abbate, M.; Zoja, C.; Remuzzi, G. How does Proteinuria Cause Progressive Renal Damage? J. Am. Soc. Nephrol. 2006, 17, 2974-2984.
54. Khajehdehi, P.; Zanjaninejad, B.; Aflaki, E.; Nazarinia, M.; Azad, F.; Malekmakan, L.; Dehghanzadeh, G.R. Oral Supplementation of Turmeric Decreases Proteinuria, Hematuria, and Systolic Blood Pressure in Patients Suffering from Relapsing Or Refractory Lupus Nephritis: A Randomized and Placebo-Controlled Study. J. Ren. Nutr. 2012, 22, 50-57.
55. Vanholder, R.; Baurmeister, U.; Brunet, P.; Cohen, G.; Glorieux, G.; Jankowski, J. European Uremic Toxin Work Group. A Bench to Bedside View of Uremic Toxins. J. Am. Soc. Nephrol. 2008, 19, 863-870.
56. Vanholder, R.; Glorieux, G.; de Smet, R.; Lameire, N. European Uremic Toxin Work Group. New Insights in Uremic Toxins. Kidney Int. 2003, 84, S6-S10.
57. Duranton, F.; Cohen, G.; de Smet, R.; Rodriguez, M.; Jankowski, J.; Vanholder, R.; Argiles, A.; European Uremic Toxin Work Group. Normal and Pathologic Concentrations of Uremic Toxins. J. Am. Soc. Nephrol. 2012, 23, 1258-1270.
58. Miyagi, M.; Ishii, H.; Murakami, R.; Isobe, S.; Hayashi, M.; Amano, T.; Arai, K.; Yoshikawa, D.; Ohashi, T.; Uetani, T.; et al. Impact of Renal Function on Coronary Plaque Composition. Nephrol. Dial. Transplant. 2010, 25, 175-181.
59. Pelisek, J.; Hahntow, I.N.; Eckstein, H.H.; Ockert, S.; Reeps, C.; Heider, P.; Luppa, P.B.; Frank, H. Impact of Chronic Kidney Disease on Carotid Plaque Vulnerability. J. Vasc. Surg. 2011, 54, 1643-1649.
60. Tousoulis, D.; Psarros, C.; Demosthenous, M.; Patel, R.; Antoniades, C.; Stefanadis, C. Innate and Adaptive Inflammation as a Therapeutic Target in Vascular Disease: The Emerging Role of Statins. J. Am. Coll. Cardiol. 2014, 63, 2491-2502.
61. Shin, S.K.; Ha, T.Y.; McGregor, R.A.; Choi, M.S. Long-Term Curcumin Administration Protects Against Atherosclerosis Via Hepatic Regulation of Lipoprotein Cholesterol Metabolism. Mol. Nutr. Food Res. 2011, 55, 1829-1840.
62. Liu, T.; Li, C.; Sun, H.; Luo, T.; Tan, Y.; Tian, D.; Guo, Z. Curcumin Inhibits Monocyte Chemoattractant Protein-1 Expression and Enhances Cholesterol Efflux by Suppressing the c-Jun N-Terminal Kinase Pathway in Macrophage. Inflamm. Res. 2014, 63, 841-850.
63. Hasan, S.T.; Zingg, J.M.; Kwan, P.; Noble, T.; Smith, D.; Meydani, M. Curcumin Modulation of High Fat Diet-Induced Atherosclerosis and Steatohepatosis in LDL Receptor Deficient Mice. Atherosclerosis 2014, 232, 40-51.
64. Ghosh, S.S.; Bie, J.; Wang, J.; Ghosh, S. Oral Supplementation with Non-Absorbable Antibiotics Or Curcumin Attenuates Western Diet-Induced Atherosclerosis and Glucose Intolerance in LDLR-/- Mice-Role of Intestinal Permeability and Macrophage Activation. PLoS One 2014, 9, e108577.
65. Morimoto, T.; Sunagawa, Y.; Kawamura, T.; Takaya, T.; Wada, H.; Nagasawa, A.; Komeda, M.; Fujita, M.; Shimatsu, A.; Kita, T.; et al. The Dietary Compound Curcumin Inhibits p300 Histone Acetyltransferase Activity and Prevents Heart Failure in Rats. J. Clin. Investig. 2008, 118, 868-878.
66. Cruz, D.N.; Schmidt-Ott, K.M.; Vescovo, G.; House, A.A.; Kellum, J.A.; Ronco, C.; McCullough, P.A. Pathophysiology of Cardiorenal Syndrome Type 2 in Stable Chronic Heart Failure: Workgroup Statements from the Eleventh Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contrib. Nephrol. 2013, 182, 117-136.
67. Gullestad, L.; Aukrust, P. Review of Trials in Chronic Heart Failure Showing Broad-Spectrum Anti-Inflammatory Approaches. Am. J. Cardiol. 2005, 95, 17-23.
68. Sarafidis, P.A.; Ruilope, L.M. Insulin Resistance, Hyperinsulinemia, and Renal Injury: Mechanisms and Implications. Am. J. Nephrol. 2006, 26, 232-244.
69. Sun, P.P.; Perianayagam, M.C.; Jaber, B.L. Endotoxin-Binding Affinity of Sevelamer: A Potential Novel Anti-Inflammatory Mechanism. Kidney Int. 2009, 76, S20-S25.
70. Vaziri, N.D.; Yuan, J.; Rahimi, A.; Ni, Z.; Said, H.; Subramanian, V.S. Disintegration of Colonic Epithelial Tight Junction in Uremia: A Likely Cause of CKD-Associated Inflammation. Nephrol. Dial. Transplant. 2012, 27, 2686-2693.
71. Anders, HJ.; Andersen, K.; Stecher, B. The Intestinal Microbiota, a Leaky Gut, and Abnormal Immunity in Kidney Disease. Kidney Int. 2013, 83, 1010-1016.
72. Anand, P.; Kunnumakkara, A.B.; Newman, RA.; Aggarwal, B.B. Bioavailability of Curcumin: Problems and Promises. Mol. Pharm. 2007, 4, 807-818.
73. Sharma, RA.; Steward, W.P.; Gescher, A.J. Pharmacokinetics and Pharmacodynamics of Curcumin. Adv. Exp. Med. Biol. 2007, 595, 453-470.
74. Metzler, M.; Pfeiffer, E.; Schulz, S.I.; Dempe, J.S. Curcumin Uptake and Metabolism. Biofactors 2013, 39, 14-20.
75. Hoyer, J.; Schulte, K.L.; Lenz, T. Clinical Pharmacokinetics of Angiotensin Converting Enzyme (ACE) Inhibitors in Renal Failure. Clin. Pharmacokinet. 1993, 24, 230-254.
76. Schachter, M. Chemical, Pharmacokinetic and Pharmacodynamic Properties of Statins: An Update. Fundam. Clin. Pharmacol. 2005, 19, 117-125.
77. Ramezani, A.; Raj, D.S. The Gut Microbiome, Kidney Disease, and Targeted Interventions. J. Am. Soc. Nephrol. 2014, 25, 657-670.
78. Vaziri, N.D.; Yuan, J.; Nazertehrani, S.; Ni, Z.; Liu, S. Chronic Kidney Disease Causes Disruption of Gastric and Small Intestinal Epithelial Tight Junction. Am. J. Nephrol. 2013, 38, 99-103.
79. Vaziri, N.D. CKD Impairs Barrier Function and Alters Microbial Flora of the Intestine: A Major Link to Inflammation and Uremic Toxicity. Curr. Opin. Nephrol. Hypertens. 2012, 21, 587-592.
80. Carvalho, B.M.; Guadagnini, D.; Tsukumo, D.M.; Schenka, A.A.; Latuf-Filho, P.; Vassallo, J.; Dias, J.C.; Kubota, L.T.; Carvalheira, J.B.; Saad, M.J. Modulation of Gut Microbiota by Antibiotics Improves Insulin Signalling in High-Fat Fed Mice. Diabetologia 2012, 55, 2823-2834.
81. Adesso, S.; Popolo, A.; Bianco, G; Sorrentino, R; Pinto, A.; Autore, G.; Marzocco, S. The Uremic Toxin Indoxyl Sulphate Enhances Macrophage Response to LPS. PLoS One 2013, 8, e76778.
82. Huang, W.T.; Niu, K.C.; Chang, CK.; Lin, M.T.; Chang, C.P. Curcumin Inhibits the Increase of Glutamate, Hydroxyl Radicals and PGE2 in the Hypothalamus and Reduces Fever during LPS-Induced Systemic Inflammation in Rabbits. Eur. J. Pharmacol. 2008, 593, 105-111.
83. Charalambous, B.M.; Stephens, R.C.; Feavers, I.M.; Montgomery, H.E. Role of Bacterial Endotoxin in Chronic Heart Failure: The Gut of the Matter. Shock 2007, 28, 15-23.
84. Edelblum, K.L.; Turner, J.R. The Tight Junction in Inflammatory Disease: Communication Breakdown. Curr. Opin. Pharmacol. 2009, 9, 715-720.
85. Bentala, H; Verweij, W.R.; Huizinga-Van der Vlag, A.; van Loenen-Weemaes, A.M.; Meijer, D.K.; Poelstra, K. Removal of Phosphate from Lipid A as a Strategy to Detoxify Lipopolysaccharide. Shock 2002, 18, 561-566.
86. Lalles, J.P. Intestinal Alkaline Phosphatase: Novel Functions and Protective Effects. Nutr. Rev. 2014, 72, 82-94.
87. Wang, Y.; Lu, Z.; Wu, H; Lv, F. Study on the Antibiotic Activity of Microcapsule Curcumin against Foodborne Pathogens. Int. J. Food Microbiol. 2009, 136, 71-74.
88. Prasad, S.; Tyagi, A.K.; Aggarwal, B.B. Recent Developments in Delivery, Bioavailability, Absorption and Metabolism of Curcumin: The Golden Pigment from Golden Spice. Cancer. Res. Treat. 2014, 46, 2-18.
89. Zhongfa, L.; Chiu, M.; Wang, J.; Chen, W.; Yen, W.; Fan-Havard, P.; Yee, L.D.; Chan, K.K. Enhancement of Curcumin Oral Absorption and Pharmacokinetics of Curcuminoids and Curcumin Metabolites in Mice. Cancer Chemother. Pharmacol. 2012, 69, 679-689.
90. The Global Issue of Kidney Disease. Lancet 2013, 382, 101.